Sichuan Huiyu Pharmaceutical Co. Ltd. Class ASSE: 688553

"SICHUAN HUIYU PHARMACEUTICAL CO., LTD."Announcement on Voluntary Disclosure of Obtaining the Notice of Approval for Clinical Trial of HY07121 for Injection (Subcutaneous Injection)

Aug 20, 2026 · Issued by Sichuan Huiyu Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange

Announcement on Voluntary Disclosure of Obtaining the Notice of Approval for Clinical Trial of HY07121 for Injection (Subcutaneous Injection)

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Sichuan Huiyu Pharmaceutical Co. Ltd. Class A

"SICHUAN HUIYU PHARMACEUTICAL CO., LTD."Announcement on Voluntary Disclosure of Obtaining Overseas Marketing Authorization for the Company's ProductsAug 11
"SICHUAN HUIYU PHARMACEUTICAL CO., LTD."Announcement on Controlled Subsidiary's Acceptance of Financial Assistance from Related PartiesAug 8
"SICHUAN HUIYU PHARMACEUTICAL CO., LTD."Announcement on Voluntary Disclosure of Proposed Selection in the National Centralized Drug ProcurementAug 3
"SICHUAN HUIYU PHARMACEUTICAL CO., LTD."Announcement on Completing Industrial and Commercial Change Registration and Obtaining Renewed Business LicenseJul 30

All Sichuan Huiyu Pharmaceutical Co. Ltd. Class A news releases